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Microfluidic-based tissue-on-a-chip devices have generated significant research interest
for biomedical applications, such as pharmaceutical development, as they can be used
for small volume, high throughput studies on the effects of therapeutics on tissue-
mimics. Tissue-on-a-chip devices are evolving from basic 2D cell cultures incorporated
into microfluidic devices to complex 3D approaches, with modern designs aimed at
recapitulating the dynamic and mechanical environment of the native tissue. Thus far,
most tissue-on-a-chip research has concentrated on organs involved with drug uptake,
metabolism and removal (e.g., lung, skin, liver, and kidney); however, models of the
drug metabolite target organs will be essential to provide information on therapeutic
efficacy. Here, we develop an osteogenesis-on-a-chip device that comprises a 3D
environment and fluid shear stresses, both important features of bone. This inexpensive,
easy-to-fabricate system based on a polymerized High Internal Phase Emulsion
(polyHIPE) supports proliferation, differentiation and extracellular matrix production of
human embryonic stem cell-derived mesenchymal progenitor cells (hES-MPs) over
extended time periods (up to 21 days). Cells respond positively to both chemical and
mechanical stimulation of osteogenesis, with an intermittent flow profile containing rest
periods strongly promoting differentiation and matrix formation in comparison to static
and continuous flow. Flow and shear stresses were modeled using computational
fluid dynamics. Primary cilia were detectable on cells within the device channels
demonstrating that this mechanosensory organelle is present in the complex 3D culture
environment. In summary, this device aids the development of ‘next-generation’ tools
for investigating novel therapeutics for bone in comparison with standard laboratory and
animal testing.
Keywords: organ-on-a-chip, mechanotransduction, polyHIPE, additive manufacture, bioreactor, computational
fluid dynamics, tissue engineering
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INTRODUCTION
One of the main impediments to drug development is the
associated cost of assessing potential hazards, side effects and
toxicity using pre-clinical animal testing. Clearly these are
essential steps in the drug development process; however, whilst
conventional in vivo testing approaches are viewed as the gold
standard for evaluating new therapeutics they are not without
shortcomings. For example, the majority of animal testing is
performed in rodents despite there being a lack of similarity in the
physiology and immune systems of these animals and humans.
These differences are likely to be the cause of the poor translation
of in vivo pre-clinical efficacy to human trials (McGonigle and
Ruggeri, 2014; Malfait and Little, 2015).
A potential method of overcoming these limitations is using
in vitro models to replace some facets of animal testing
(Owen and Reilly, 2018). Traditionally, most in vitro approaches
have consisted of culturing cells as a monolayer on planar,
“two-dimensional (2D)” surfaces. Whilst being informative,
these simple systems fail to recreate the structural and
dynamic mechanical complexity of the three-dimensional (3D)
environment observed within tissues and organs and therefore
only provide limited information about potential tissue responses
(Owen et al., 2020a).
Microfluidic cell culture platforms and “organ-on-a-
chip” devices have the potential to considerably advance
biological research, drug development, and resource efficiency
by combining both structural and dynamic cues within in vitro
models (Hadida and Marchat, 2019). The combination of
recent advances in additive manufacturing, bioprinting and
microfluidics has resulted in a surge in their development and
production (Huh et al., 2011; Neuži et al., 2012). Understandably,
within this research area much of the focus has been on creating
models of organs involved in drug metabolism and clearance,
for example liver and kidney models (Chao et al., 2009; Novik
et al., 2010; Ferrell et al., 2012). However, in the future it will be
crucial to also have models of target organs for the therapeutics
of interest. Within this area, some microfluidic models of other
organs, such as lung (Hinderer et al., 2012; Huh et al., 2012),
gastrointestinal (GI) tract (Pusch et al., 2011; Esch et al., 2012),
skin (Brauchle et al., 2013; Wagner et al., 2013), bone marrow
(Torisawa et al., 2014; Sieber et al., 2018), and bone (Bersini
et al., 2014; Hao et al., 2018), have been researched. A recent
review by Scheinpflug et al. (2018), examines microfluidic,
organ-on-a-chip approaches to modeling different aspects of
bone in vitro. The ultimate hope is that by connecting different
organ models together within one human-on-a-chip framework,
the opportunity to study the effects of drugs and their metabolites
on multiple organs will arise (Maschmeyer et al., 2015) with
the potential to accelerate drug development significantly
(Esch et al., 2014).
Traditional microfluidic devices are a clear improvement
in physiological relevance when compared to traditional static
cell culture due to the presence of fluid flow and fluid shear
stress (FSS). However, despite these advances, many microfluidic
devices remain “2D” at the cell-scale as cells are still ultimately
cultured on a planar surface. This lack of a 3Dmicroenvironment
results in cells having a different morphology, polarity, and
behavior to that observed in 3D cell culture and in vivo (Baker
and Chen, 2012). Fortunately, advances within the parallel field of
tissue engineering have revealed a range of approaches that can be
used to generate 3D tissues in vitro, the principles of which can be
adapted for and incorporated within microfluidic tissue-mimics.
Bone is a prime example of a tissue that requires both a
3D microenvironment and fluid flow for an accurate in vitro
model to be produced. The field of bone tissue engineering
allows us to address the structural problem by combining
the culture of osteoprogenitor cells with scaffolding materials
that provide a template for cell growth and the formation
of bone-like extracellular matrix and specialized media that
provide the essential chemical cues for bone development.
Many different materials have been used for bone tissue
engineering, ranging from metals and ceramics to natural
and synthetic polymers (Bose et al., 2012; Roseti et al., 2017;
Owen and Reilly, 2018). However, of notable recent interest is
the development of polymerized high internal phase emulsion
(polyHIPE) materials as polymeric scaffolds for bone tissue
engineering (Robinson et al., 2016; Lee et al., 2017; Paterson
et al., 2018; Aldemir Dikici et al., 2019; Aldemir Dikici and
Claeyssens, 2020; Owen et al., 2020b). PolyHIPEs are inherently
porous materials that are formed by emulsion templating;
the emulsion consists of a curable continuous phase that
encapsulates an immiscible internal droplet phase where the
internal phase volume exceeds 74%. The continuous phase
is then polymerized to produce a highly porous material
with extensive pore interconnectivity where the percentage
porosity is simply the internal phase volume ratio. Our previous
work has demonstrated that by making the continuous phase
photocurable, it is possible to additively manufacture polyHIPEs
(Owen et al., 2015, 2016; Malayeri et al., 2016; Wang et al., 2016;
Sherborne et al., 2018).
In this study, we detail for the first time the design,
development, and assessment of a microfluidic osteogenesis-
on-a-chip device that incorporates a reproducible 3D polymer
scaffold and physiologically relevant flow conditions. The design
was composed of two separate parts; a photocurable polyHIPE
scaffold that is embedded within a silicone-based polymer
microfluidic unit. To assess device efficacy, human embryonic
stem cell-derived mesenchymal progenitor cells (hES-MPs) were
cultured for up to 3 weeks. Different flow rates and flow
profiles were examined, comparing metabolic activity, osteogenic
differentiation, and mineralized matrix deposition.
RESULTS AND DISCUSSION
Bone Microfluidic Chip Design
We set out to design a bone microfluidic chip that fulfilled
the requirements of being suitable for osteoblast culture by
incorporating a 3D bone tissue engineering scaffold and
physiologically relevant flow conditions, as well as being simple
to manufacture en masse, reproducible, and cost effective. To
achieve this, a two-part device consisting of a bioreactor and
scaffold was designed where each component could quickly
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FIGURE 1 | AutoCAD design of the bone microfluidic chip (A) 2-D and (B) 3D view of the combined bioreactor and polyHIPE scaffold. Dimensions are in mm.
(C) Schematic/exploded view of the chip components, including the microfluidic bioreactor, polyHIPE scaffold and a cover slip. (D) Photograph of the assembled
chip with a £1 (GBP) coin for scale.
be reproducibly and easily fabricated through reusable molds
(Figures 1A,B).
The bioreactor has two manifolds to act as an inlet and
outlet, each consisting of a 2 mm diameter main channel
and three 430 µm sub-channels which lead to the scaffold
chamber. These channels are responsible for transporting media
into and out of the microfluidic chip. The scaffold has a
uniform repeating pattern of regular, congruent hexagonal
pillars 280 µm in height with a side length of 690 µm
protruding from a base 220 µm deep (total height 500 µm).
Each pillar is separated by a 310 µm channel to allow
regular flow through the chip. A hexagonal rather than
circular pillar design was adopted to ensure that the channel
width was the same throughout. From our computational
fluid dynamics (CFD) assessment we observed that this
reduces the variation in pressure and shear stress (see
Supplementary Information).
Bone Microfluidic Chip Fabrication and
Assembly
The molds for both the bioreactor and scaffold component were
fabricated from polyethylene glycol diacrylate (PEG-DA) using
stereolithography in order to exercise precise control over the
final architecture in comparison to other additive manufacturing
techniques such as extrusion printing (Melchels et al., 2010).
The bioreactor component of the bone microfluidic
chip was formed using negative replica molding with the
final polydimethylsiloxane (PDMS) part produced directly
from the PEG-DA mold. PDMS is a popular material for
fabricating microfluidic devices due to its biocompatibility,
oxygen permeability, transparency, and ease of molding into
micron-scale features (Zhou et al., 2010), and it was for
these reasons it was selected for the bioreactor component.
Despite its prevalence in the field of microfluidics, it
is worth noting that it is not the ‘perfect’ material as
it readily absorbs organic solvents, biological molecules
and drugs (Mukhopadhyay, 2007). Therefore, whilst the
proof-of-concept device described here relies on PDMS
to contain the device, further optimization could identify
an alternative material for the bioreactor component to
alleviate this problem.
The scaffold component of the chip was fabricated from a
polyHIPE using a two-step molding process where a PDMS
negative was first produced from a PEG-DA mold, and this
was subsequently used to cast the polyHIPE. To assemble the
bone microfluidic chip, a plasma-treated polyHIPE scaffold was
inserted into the chamber of the PDMS bioreactor and this unit
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covalently bound onto a glass slide using air plasma to seal the
microfluidic chip (Figures 1C,D).
The polyHIPE material was selected to fabricate the scaffold
housed within the bioreactor as over the last decade emulsion
templating has been demonstrated to be an excellent way of
producing 3D scaffolds for cell culture, exemplified by the
commercialization of Alvetex R© (Knight et al., 2011). Recent
publications have structured the polyHIPE used here into
complex 3D architectures using stereolithography to create
scaffolds for bone tissue engineering (Owen et al., 2016;
Sherborne et al., 2018). However, direct laser writing of these
emulsions is relatively slow when compared to other scaffold
manufacturing techniques. The comparative simplicity of the
scaffold produced here made it possible to accurately produce
this structure by casting the polyHIPE rather than individually
printing each scaffold, an approach which increases device
manufacture throughput.
PolyHIPE Morphology Is Not Affected by
Mold Stamping
Physical characterization of the polyHIPE scaffold was performed
using scanning electron microscopy (SEM) (Figures 2A–E). The
classical polyHIPE morphology was observed within the scaffold,
demonstrating that the stamping process produced an open
surface porosity with no adverse effects such as surface skin
formation, which can occur during other fabrication methods
(Kimmins and Cameron, 2011; Sherborne et al., 2018). Pore
size distribution was analyzed using eight different SEM images
taken from different scaffolds using the measurement tool
within ImageJ (Schneider et al., 2012) (Figure 2F). Since the
pore bisection is not always in the equatorial plane of the
pore, a statistical correction factor was applied to take this
underestimation into account and calculate a more accurate
diameter (Barbetta and Cameron, 2004; Owen et al., 2016). The
inherent polyHIPE pore sizes ranged from 5 to 30 µm, a scale
suitable for cell attachment, proliferation, ingrowth and nutrient
transfer. The average pore diameter within the polyHIPE scaffold
was 15.90± 6.11 µm.
It is feasible that a monolith of the polyHIPE could have
been used over the more complex channel design as flow
through the scaffold would still have been achievable due to
the high level of interconnected porosity. However, a design
which incorporated regular channels was chosen for several
reasons. First, in amonolithic design only smaller, cell-sized pores
would be present which may result in blockage as extracellular
matrix is produced. This would limit nutrient and waste transfer
and subsequently the maximum possible duration of culture.
Therefore, we hypothesized that the inclusion of channels would
permit even distribution of flow within the scaffolds for longer
durations before they become filled with matrix, maximizing
culture duration. Second, the presence of channels increases the
achievable flow velocity and subsequent shear stress which can
be applied within the chip. Finally, forming channels within
the polyHIPE introduces a multiscale, micro- to macro-scale
porosity where macropores (the channels) are present between
the microporous pillars and base of the scaffold. This hierarchical
porosity is observed in native bone tissue (Genthial et al., 2017)
and has been demonstrated to be beneficial for osteoblast activity
(Owen et al., 2016; Sherborne et al., 2018).
Previously, microfluidic devices which incorporate a 3D
architecture have been developed for study of vascularization of
bone, hematopoiesis and cancer metastasis in bone (Bersini et al.,
2014; Torisawa et al., 2014; Hao et al., 2018; Scheinpflug et al.,
2018; Sieber et al., 2018); however, these rely on the use of random
architecture ceramic scaffolds, deposited extracellular matrix, or
collagen gels to provide the required 3D microenvironment.
Furthermore, where the use of human or animal components
in the creation of the 3D environment, availability is limited,
standardization is difficult, and it is not a methodology amenable
to truly replacing animal testing (Scheinpflug et al., 2018).
Therefore, whilst these approaches do provide the geometric
cues required to mimic native bone, they lack the inter-chip
reproducibility required for systematic drug studies. Despite the
precise micropore position within the polyHIPE being non-
specified as it is dictated by water droplet position at the
time of polymerization, the overall porosity (total porosity,
pore distribution, pore size) of the material is highly consistent
between samples and batches of the material, as evidenced by the
small standard deviation of the pore size analysis within this study
and the degree of openness characterization performed by Owen
et al. (2016). Therefore, the reproducibility of the whole scaffold
used within the chip remains high; an important requirement for
controlled pre-clinical evaluation of pharmaceuticals.
Higher Flow Rates Compromise Initial
Cell Attachment but Not Long-Term
Growth
Fluid shear stress is exerted in vivo when bone is deformed.
It is thought to be sensed by cells through mechanoreceptors
such as the primary cilia (Delaine-Smith and Reilly, 2012), which
in turn promote factors that stimulate osteoblast differentiation
and bone formation (Johnson et al., 1996; Sikavitsas et al.,
2003; Wu et al., 2006; Temiyasathit and Jacobs, 2010). It
has been previously demonstrated that when FSS is applied
in vitro, osteogenic differentiation is promoted and limitations
on nutrient transfer in larger constructs is mitigated. Efficacy of
in vitromechanical stimulation is sensitive to several parameters,
such as magnitude of the stimulation, number of cycles and
frequency. Although bone is typically loaded in vivo in a
cyclic manner, in vitro there are contradicting reports about
whether oscillating flow profiles are superior to other flow
modalities at promoting osteogenesis, with studies finding it both
better and no different to unidirectional flow (Du et al., 2009;
Case et al., 2011).
To assess the suitability of the bone microfluidic chip for
cell growth and differentiation, hES-MPs were cultured for up
to 3 weeks inside the chip in osteogenesis induction media
(OIM). To identify the optimum flow profile, different flow rates
and patterns were examined. Initially, four different continuous
unidirectional flow rates (0.8, 1.6, 2.4, and 3.2 mL/min) were
compared to a static control over a 7-days period with metabolic
activity assessed on day 7 (Figure 3).
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FIGURE 2 | PolyHIPE scaffold morphology. (A–E) SEM image of 80% porosity polyHIPE scaffold at increasing magnifications. (F) Histogram of pore diameter
distribution based on eight different SEM image analysis (n = 200).
As the flow rate increased, cell metabolic activity
decreased, with significantly lower metabolic activity in
comparison to static at flow rates above 1.6 mL/min
(Figure 3C). At the highest flow rate, cell metabolic activity
after 7 days is almost 50% of that of the static control.
This reduction is most likely due to the detachment of
poorly attached cells at the onset of fluid flow, an effect
exacerbated by higher flow rates (Cartmell et al., 2003;
Jaasma and O’brien, 2008).
When applying fluid flow in vitro, it has been reported that
the inclusion of rest periods between flow sessions enhances
the effects of FSS. It is believed these intermittent flow profiles
allow a ‘reset’ of the signaling pathways, stopping them from
becoming saturated and allowing reactivation when flow resumes
(Robling et al., 2000, 2001; Donahue et al., 2003; Batra et al.,
2005; Srinivasan et al., 2007; Plunkett et al., 2009; Case et al.,
2011; Gong et al., 2014). When initially exposed, both continuous
and intermittent flow profiles will have the same effects as the
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FIGURE 3 | Photographs of (A) the Ibidi fluidic system and (B) a single fluidic unit. (C) Cell metabolic activity on day 7 normalized to static control for four different
flow rates (0.8, 1.6, 2.4, and 3.2 mL/min). As flow rate increases, metabolic activity decreases (*p < 0.05, **p < 0.01) (n = 4). (D) Photograph showing a perfused
bone microfluidic chip connected to the commercial Ibidi perfusion pump system with ruler for scale. (E,F) Comparison of metabolic activity over time with different
flow profiles. (E) Day 7 metabolic activity. Both the intermittent (0.8–3.2 mL/min) and continuous (3.2 mL/min) flow profiles have significantly lower metabolic activity
after 1 week than the static control, although the intermittent is significantly higher than the continuous. (F) By day 21 the cell metabolic activity has recovered for
both intermittent and continuous flow profiles, resulting in no significant difference. Recovery is achieved sooner in the intermittent condition (n = 8) (*p < 0.05,
**p < 0.01).
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 6 September 2020 | Volume 8 | Article 557111
Bahmaee et al. Development of a Bone Microfluidic Device
FIGURE 4 | (A) Total DNA per chip for each flow profile on day 14. Both intermittent and continuous are significantly lower than static, with continuous significantly lower
than intermittent (n = 8) (∗p < 0.05, ∗∗p < 0.01). (B) Day 14 ALP activity normalized to total DNA. The intermittent flow profile resulted in significantly higher normalized
activity than the static control and continuous flow profile. There is no significant different between static and continuous. (C,D) Comparison of matrix deposition of
hES-MPs in three different flow conditions at day 21 in OIM. (C) Total Alizarin Red S (ARS) staining per chip, calcium content is significantly higher for intermittent flow,
there is no difference between static and continuous. (D) Total Direct Red 80 (DR80) staining per chip, collagen deposition is also significantly higher for intermittent
flow, no difference between static and continuous. Representative images inserted below the intermittent and continuous flow conditions (n = 8) (**p < 0.01).
FSS is mechanotransduced. However, under continuous flow this
stimulation is subject to ‘diminishing returns,’ whereas under
intermittent flow where the cells are allowed to recover the
subsequent bouts of stimulation are as effective as the initial
treatment (Robling and Turner, 2009).
To assess whether the initial disruption of cell metabolic
activity by the 3.2 mL/min flow rate would impact the long-
term performance of the chip, cultures were extended to 14 and
21 days, examining metabolic activity at each time point. To
test whether the effects of a continuous high flow rate could
be alleviated by rest periods, an intermittent flow regime was
also investigated (Figures 3E,F). Previously, it has been found
in vivo that rest periods of 4 to 8 h are required to regain
mechanosensitivity of osteoblasts (Robling et al., 2001) and flow
is typically applied for bouts of up to 2 h (Michael Delaine-Smith
et al., 2015). Therefore, in this study the bone microfluidic chip
was subjected to the high flow condition (3.2 mL/min) for 90 min
followed by lowest flow condition (0.8 mL/min) for 270 min
(4.5 h) in a repeating cycle for the duration of the experiment.
A low flow rate (0.8 mL/min) was selected for the rest period
rather than zero flow as cell death was observed inside the sealed
bone microfluidic chips when a flow rate of 0 mL/min was used
(see Supplementary Information). It has been hypothesized
that in vivo, bone may be continuously mechanically stimulated
even whilst there is no skeletal movement due to blood
pressure-induced interstitial fluid flow in the lacuno-canalicular
system (Fritton and Weinbaum, 2009). However, computational
models have estimated that these flow rates and subsequent
shear stresses are less than 3% of the fluid flow that is
induced by mechanical loading, and therefore are insufficient
to promote osteogenic differentiation (Wang et al., 2003; Li
et al., 2010). Therefore, the low flow rate used during the rest
period of the intermittent flow profile in this study could be
considered more analogous to the in vivo condition than a zero
flow rate.
By day 7, cell metabolic activity was significantly lower
in the intermittent and continuous flow profiles than the
static control (Figure 3E), although the intermittent profile
had significantly higher metabolic activity than the continuous
indicating the benefits of rest periods. Despite this, by day
21 there was no significant difference in metabolic activity
between any of the conditions, indicating that the initially
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FIGURE 5 | Representative fluorescence and confocal microscopy and histological sections of hES-MPs seeded in the bone microfluidic chip in OIM with the
intermittent flow profile. Yellow lines demarcate the edge of the pillars. Live CellTrackerTM images on (A) day 1 and (B) day 3 taken through the PDMS chamber.
(C–F) Day 14 confocal images of nuclei stained with DAPI (blue) and actin with phalloidin-TRITC (red). Individual color channels and composite shown. The control
was not autofluorescent, hence it appears black. Cells are present throughout the channels and pillar walls. (G) Low magnification and (H) high magnification 8 µm
histology section stained with H&E stain. Cells can be seen throughout the channels to the height of the pillars, as well as within the interconnected porous network
of the polyHIPE bulk material.
lower cell metabolic activity is recovered over time (Figure 3F).
Although the intermittent flow profile recovered to the levels
of the static control before the continuously flowed samples,
this appears to be due to a smaller initial loss of cells
when flow was first applied rather than a faster recovery
rate as the gradients of the intermittent and continuous
profiles are comparable.
An Intermittent Flow Profile Promotes
Differentiation and Enhances Mineralized
Matrix Deposition
In order to examine whether either the intermittent or
continuous flow profile has any effect on osteogenic
differentiation and mineralized matrix production, bone
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microfluidic chips were maintained in OIM for up to 21 days
with either the static, intermittent (0.8–3.2 mL/min) or
continuous (3.2 mL/min) flow profile. ALP activity and total
DNA were quantified on day 14 and calcium deposition and
collagen production on day 21.
Total DNA agreed with the metabolic activity data that
cell number is indeed lower when cells were exposed to
flow (Figure 4A). When an intermittent unidirectional flow
profile was applied, ALP activity, calcium deposition and
collagen synthesis were 2.3, 1.8, and 2.2 times higher than
the continuous flow profile, respectively (Figures 4B–D).
Interestingly, for both ALP activity and matrix deposition,
there was no significant difference between the static condition
and continuous flow profile. These data demonstrate that
the shear stresses the cells are exposed to during the
3.2 mL/min flow rate have the potential to promote osteogenic
differentiation, but only when combined with intermittent rest
periods. This agrees with previous work which found that
rest periods in mechanical stimulation protocols significantly
promoted osteogenesis of progenitor cells in comparison
to continuous flow (Robling et al., 2000; Batra et al.,
2005; Srinivasan et al., 2007; Kreke et al., 2008; Case
et al., 2011). It is worth noting that in this study only
unidirectional continuous and intermittent flow profiles were
compared. However, future work on this system should include
optimization of the flow rate and rest interval, and also compare
oscillating flow as bone is typically loaded cyclically in vivo
during normal gait.
Cells Penetrate the PolyHIPE Network
and Fill the Channels Within the Chip
In situ monitoring of cells was possible due to the transparency
of the PDMS bioreactor component. To determine how cells
behave within the microfluidic unit, hES-MPs were stained
with CellTrackerTM and cultured for 14 days in OIM with
the intermittent flow profile. Live cells were imaged on days 1
(Figure 5A) and 3 (Figure 5B) with fluorescence microscopy
before fixing and examining with confocal microscopy and
histology on day 14 (Figures 5C–H).
The presence of cells within the channels could easily
be detected at early timepoints by staining cells with
CellTrackerTM prior to seeding, although subsequent cell
divisions result in an attenuated signal over time. Confocal
microscopy revealed cells throughout the channels within the
polyHIPE scaffold through the staining of nuclei (blue) and
the cytoskeleton (red). Histology allowed a cross-sectional
view of the scaffold, revealing that not only are cells present
within the channels, but also within the interconnected
porous network of the bulk polyHIPE material, indicating full
penetration of the material. These could not be observed using
confocal microscopy due to the light scattering nature of the
polyHIPE limiting infiltration into the material. Despite the
initially lower cell attachment in comparison to static of the
intermittent flow profile, it is clear that significant quantities
of extracellular matrix was still deposited within the channels
of the scaffold.
FIGURE 6 | Comparison of day 14 normalized ALP activity of bone
microfluidic chips maintained with the intermittent flow profile in either OIM or
SM. As with Figure 4, ALP activity was significantly higher with intermittent
flow on OIM. However, there was minimal ALP activity in chips maintained in
SM, regardless of flow profile (n = 4) (**p < 0.01).
Fluid Shear Stress Alone Is Not Enough
to Induce Osteogenic Differentiation
Due to the potent nature of the intermittent flow profile, it was
investigated whether mechanical stimulation alone is sufficient
to induce osteogenic differentiation of hES-MPs. Chips were
maintained in either OIM or supplemented media (SM, OIM
without dexamethasone) for 14 days with the intermittent flow
profile (Figure 6). The difference between these media is that
OIM contains dexamethasone, a glucocorticoid that is a powerful
promoter of osteogenic differentiation. Both media contained
βGP and AA2P, supplements required for matrix mineralization
and collagen synthesis, respectively.
As in Figure 4, normalized ALP activity was significantly
higher when chips were maintained in OIM for 14 days
with the intermittent flow profile. However, ALP activity was
significantly lower in SM than OIM regardless of flow profile,
with no significant effect of intermittent flow on ALP activity
in comparison to the static control. This is in agreement with
other studies examining the effect of FSS on hES-MPs (Delaine-
Smith et al., 2012; Puwanun et al., 2018), demonstrating that FSS
may enhance differentiation and bone formation, but alone is not
sufficient to induce osteogenic differentiation.
Primary Cilia Are Present Within the
Bone Microfluidic Chip
Onemechanism by which FSS is thought to be transduced by cells
is via the primary cilium. To identify whether thismechanosensor
could be detected within the chip, cultures were examined after
7 days by light sheet microscopy with antibody staining for this
mechanosensory organelle. Day 7 was selected as primary cilia
only begin to form once cells have stopped undergoing mitosis,
meaning that there are fewer to detect during the growth phase
in the first week of culture.
Primary cilia were found to be present on cells in the channels,
indicating they would be exposed to fluid flow through the chip
and are a potential mechanism by which the applied FSS could
be mechanotransduced within the device (Figure 7). Although
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FIGURE 7 | Representative light-sheet images at (A) low and (B,C) high magnification of nuclei stained with DAPI (blue) and primary cilia stained with anti-acetylated
alpha tubulin (green). White arrow heads and circles indicate primary cilia. Yellow lines demarcate the edge of the pillars.
this was the only location where primary cilia were visible, this
does not mean that they are not present on cells within the
bulk of the polyHIPE, only that they could not be visualized
here. Due to the autofloresence and light scattering nature of
the polyHIPE, fluorescent imaging of such a small organelle
within the polyHIPE network in situ was not possible. However,
as they develop on the majority of quiescent mammalian cells
including osteoblast-lineage cells, and are visible elsewhere in
the same culture, it is highly likely they are also present on cells
within the polyHIPE.
The appearance of the majority of cells on the left side of
the image is not due to a difference in cell density, but because
of the imaging modality. The lightsheet generated during this
microscopy technique is not perfectly planar, it is thicker at
the edges, meaning that a greater signal is generated here and
a thicker z slice. It would be interesting to assess whether
the different flow profiles examined here had any effect on
the orientation or length of the cilia. However, quantitative
measurement of cilia is notoriously difficult in 3D cell culture
in general, and impossible in this study as the working distance
of the lenses required to achieve sufficient magnification have a
working distance shorter than the channel depth of the scaffold,
meaning the cells cannot be focused upon.
Computational Fluid Dynamics
Estimates of Flow Parameters
Computational fluid dynamics was used to approximate the
fluid velocity and FSS distribution within the bone microfluidic
chip during the high flow period of the intermittent flow
profile (Figure 8). Flow through the bulk polyHIPE material
was determined experimentally via a pressure drop experiment
through a defined thickness disk of the polyHIPE. The pressure
drop was then simulated, and the material porosity adjusted in
the simulation to correlate with the experimental results (see
Supplementary Information).
Although there was minimal variation in media velocity
through the scaffold, pressure decreased by approximately 450 Pa
as it progressed (Figure 8B). Shear stress at the interface between
the channels and the surface of the polyHIPE could not be
plotted as flow is not tangential as it also goes through the
polyHIPEmaterial. Therefore, the simulation was repeated where
the polyHIPE components were assumed to be non-porous to
allow the shear stress to be approximated. At the base of the
channels, this was approximately 0.8 to 1.4 Pa (Figure 8C). It is
interesting to note that the shear stress experienced by the cells
on the surface of the chip scales linearly with the flow, from 0.2–
0.4 Pa at 0.8 mL/min to 0.8–1.4 Pa at 3.2 mL/min. The highest
flow rate used in this study was 3.2mL/min, which using CFDwas
calculated to correspond to a shear stress of 0.8 to 1.4 Pa. Were it
possible to accurately model the shear stress at the interface of the
porous material, these shear stress values would be slightly lower.
This is because the velocity in the center of channel would be
slightly lower than modeled as some flow would go through the
polyHIPE pillars. Furthermore, the velocity at the interface of the
porous pillars and channel is actually slightly greater than zero.
Despite the actual shear stress being slightly lower than modeled,
it remains in the range of estimated in vivo shear stress in bone of
0.8 to 3 Pa (Weinbaum et al., 1994; Rubin et al., 2006).
SUMMARY
In summary, organ/tissue-on-a-chip technologies have the
potential to revolutionize pharmaceutical pre-clinical testing
by increasing throughput whilst minimizing the financial and
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FIGURE 8 | Computational fluid dynamics (CFD) results for the bone microfluidic chip at inlet flow rate of 3.2 mL/min. (A) Velocity and (B) pressure as media passes
through the chip (left to right). (C) Shear stresses at the bottom of the channels if the polyHIPE is assumed to be non-porous.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 11 September 2020 | Volume 8 | Article 557111
Bahmaee et al. Development of a Bone Microfluidic Device
ethical concerns associated with in vivo evaluation. Since its
inception, great efforts have gone into developing these devices
for many organ types, but thus far bone has been comparatively
overlooked. We have successfully created a microfluidic platform
that contains the necessary 3D architecture and physiologically
relevant FSS for an osteogenesis-on-a-chip device suitable for
long-term culture. This has the potential to provide more
accurate, cheaper and faster methods of investigating novel
therapeutics for bone and sequestering of toxins into bone, in
comparison to standard in vitro and in vivo testing.
EXPERIMENTAL
Ethics approval was not required for this study.
Materials
All chemicals were purchased from Sigma-Aldrich,
United Kingdom unless otherwise stated.
Bone Microfluidic Chip Fabrication –
Bioreactor
To fabricate the bioreactor component of the bone microfluidic
chip negative replica molding was utilized. The mold was created
using stereolithography from polyethylene glycol diacrylate
700 g/mol (PEG-DA) made photocurable by incorporating
a photoinitiator [diphenyl (2,4,6-trimethylbenzoyl)-phosphine
oxide/2-hydroxy-2-methylpropiophenone, 50/50] at 4 wt%. To
fabricate molds, glass slides were first cleaned using piranha
solution (80% sulfuric acid: 20% hydrogen peroxide) for
3 h, washed with deionized water (diH2O), then placed in
10% MAPTMS [3-(trimethoxysilyl) propyl-methacrylate] in
toluene (Fisher Chemical, United Kingodm) overnight at room
temperature to add methacrylate groups to the surface. When
required, slides were washed with methanol (Fisher Chemical,
United Kingdom), and air dried. Photocurable PEG-DA was
then added to the surface of the slide and structured into
the mold using a picosecond PULSEAS P 355-300 laser.
A 355 nm wavelength was separated by optical prism and
focused through an objective lens with 10 × magnification
(NA = 0.3) onto the glass slide-PEG-DA interface. A shutter was
placed between the prism and the focusing lenses to allow beam
modulation. Using a computer-aided design (CAD) application
(A3200 movement composer, Aerotech, United Kingdom), and
motorized stage capable of moving in all three axes [ANT130-XY
for xy translation and PRO115 for z translation (both Aerotech,
United Kingdom)], the focal spot of the laser was translated to
produce the mold.
To enable easy pattern transfer and improve mold durability,
an ultra-thin film of titanium (1.7 nm as determined by
Quartz Crystal Microbalance) was coated on the surface via
sputter coating. To create the bioreactor, the mold was used
to stamp polydimethylsiloxane (PDMS, Sylgard 184, Dow
Corning, United States). First, molds were cleaned using
pressurized air, the silicone monomer and cross-linker agent
were mixed (10:1) and the uncured PDMS poured onto the
mold and left under vacuum for degassing. After eliminating
gas bubbles, they were left for 2 h at 60◦C to polymerize.
The solid PDMS bioreactors were carefully peeled from the
molds and the inlet and outlet created using a 2 mm
biopsy punch. Finally, molds were cleaned with methanol.
Due to the low surface energy of PDMS, the molds can be
repeatedly reused.
Bone Microfluidic Chip Fabrication –
PolyHIPE Scaffold
To fabricate the polyHIPE scaffold component of the bone
microfluidic chip, positive and subsequently negative replica
molding was utilized. First, using the same protocol as the
bioreactor component, a positive replica of the desired scaffold
was produced from photocurable PEG-DA, then, a negative
replica of this was created from PDMS. This negative replica was
used to stamp the scaffolds from the polyHIPE material.
To create the polyHIPE, a HIPE composed of 70 wt%
2-ethylhexyl acrylate (EHA), 30 wt% isobornyl acrylate
(IBOA), and porosity of 80% was prepared. To prepare the
continuous phase of HIPE, the two monomers (EHA and
IBOA), and a crosslinker (trimethylolpropane triacrylate,
18.28 wt% of the monomers) were mixed to form the organic
component. A surfactant [Hypermer B246 (Croda Lubricants,
United Kingdom)], and the photoinitiator were then added at 3
and 5 wt% of the organic mass, respectively. Once combined, the
internal phase (deionized water, diH2O) was added drop-wise at
a constant rate to the continuous phase whilst stirring at 350 rpm
using a paddle stirrer (Pro40, SciQuip, United Kingdom) in a
100 mL beaker. Once added, the HIPE was stirred for a further
5 min. To prepare the polyHIPE scaffold, HIPE was poured
into the PDMS negative replica of the scaffold and polymerized
using a UV spot curer for 5 min at 100 W (Omnicure S1500,
Excelitas Technologies). Once cured, it was peeled from the
mold and washed in methanol three times before leaving
overnight to dry.
Bone Microfluidic Chip Fabrication –
Device Assembly
Prior to device assembly, the polyHIPE scaffold was air plasma
treated to overcome the inherent hydrophobicity of the material
in order to promote cell attachment in accordance with the
protocol of Owen et al. (2016). Briefly, scaffolds were placed on a
platform wrapped with aluminum foil into the plasma chamber.
The pressure inside the chamber was lowered to 0.18 mbar and
the power set to 50 W to generate the plasma. Scaffolds were
treated for 5 min.
To assemble the components, a glass slide was cleaned with
acetone, then methanol, and finally diH2O. A plasma-treated
polyHIPE scaffold was then inserted into the chamber of the
bioreactor and placed into the plasma chamber face down
along with the glass slide. The components were then plasma
treated for 30 s at 50 W before gently placing the microfluidic
chip onto the glass slide. The whole device was then left at
100◦C for 10 s in an oven to complete the covalent sealing.
A schematic of the device assembly process can be found
in Figure 1.
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Scanning Electron Microscopy
All samples were mounted on a carbon tab, sputter coated with
gold, then imaged using a Philips XL 30S FEG with an electron
beam with an energy of 15 kV. Images were analyzed using the
measurement tool in Image J.
Cell Culture
Human embryonic stem cell-derived mesenchymal progenitors
(hES-MPs) (Cellartis, Sweden) were used for all cell culture
experiments. Cells were passaged in basal media [BM, minimum
alpha medium (α-MEM, Lonza, United Kingdom], 10%
fetal bovine serum (FBS, Labtech, United Kingdom), 2 mM
L-glutamine, 100 µg/mL streptomycin and 100 U/mL penicillin),
supplemented with 4 ng/mL human fibroblastic growth factor
(Life Technologies, United Kingdom) in gelatine-coasted T75
flasks at 37◦C, 5% CO2. Only cells between the 8th and 10th
passage were used.
During experiments, hES-MPs were cultured in either OIM
or supplemented media (SM). OIM is BM supplemented
with ascorbic acid 2-phosphate (AA2P, 50 µg/mL, beta-
glycerophosphate (βGP, 5 mM) and dexamethasone (100 nM).
SM is the same composition as OIM but without dexamethasone.
To apply fluid flow to the chips, a commercial perfusion pump
system (Ibidi, Germany) was used inside a standard incubator.
To sterilize the chips, 70% ethanol was circulated through the
chip for 2 h. Afterward, sterile PBS was flushed through the
device three times, once per hour. Finally, to promote cell
attachment, FBS was circulated for 12 h prior to seeding. To
seed, 120,000 cells in 30 µL BM (∼110,000 cells/cm2) were
injected through the inlet in the bioreactor and incubated for
1 h without flow to attach. Subsequently, either OIM or SM
was perfused through the chips for up to 3 weeks with different
unidirectional flow regimens. Flow was either continuous or
intermittent. Continuous flow rates were either 0.8, 1.6, 2.4, or
3.2 mL/min, whilst the intermittent flow profile was 270 min of
0.8 mL/min followed by 90 min of 3.2 mL/min, repeated as a
6 h loop throughout the experiment. The required amount of the
desired media was added to the pump’s syringes at the start of
the experiment to cover the nutrient demand over time. Media
was recirculated.
Cell death was observed after 24 h inside the sealed bone
microfluidic chip when a flow rate of 0 mL/min was used (see
Supplementary Information). Therefore, the static condition
controls were seeded by adding a droplet of 120,000 cells in
30 µL of BM to the polyHIPE scaffold and leaving to attach for
1 h before adding 2 mL of either OIM or SM. Samples were
maintained as an open culture within a well plate with media
changes every 2–3 days.
Resazurin Reduction Assay
Resazurin reduction (RR) assays were implemented to assess cell
metabolic activity. 10 vol% resazurin solution (1 mM resazurin
sodium salt in diH2O) was diluted in BM to make RR working
solution. Scaffolds were removed from the chip and placed in well
plates in 1 ml of the working solution, wrapped in aluminum foil
and incubated for 4 h. Afterwards, 200 µl of the reduced solution
was transferred to a 96 well plate in triplicate and read on a plate
reader (Tecan infinite 200-pro) at λex: 540 nm, λem: 590 nm.
Cell Digestion
To produce lysates for ALP activity and DNA assays, scaffolds
were removed from the chip, and added to 1 mL of cell digestion
buffer (10 vol% cell assay buffer: 1.5M Tris-HCl, 1 mM ZnCl2,
1 mM MgCl2 in diH2O) in diH2O with 1 vol% Triton-X
100) in a well plate. They were then incubated for 30 min
before being pulverized and the mixture transferred to a 1.5 mL
microcentrifuge tube. Samples were refrigerated overnight, then
exposed to a freeze-thaw cycle (−80◦C, 10 min; 37◦C, 15 min)
three times, centrifuged for 5 min at 10,000 rpm and vortexed.
Alkaline Phosphatase Activity
20 µL of cell lysate was combined with 180 µL of assay
substrate [pNPP Substrate Kit (Thermo Fisher Scientific,
United Kingdom)] in triplicate in a clear 96 well plate. The
mixture was left at room temperature until a slight color
change to yellow was observed or 30 min had passed to ensure
measurements were taken during the linear phase of the reaction.
Absorbance was then measured at 405 nm every minute for
30 min. ALP activity is expressed as nmol of pNP/minute, where
one absorbance value equates to 19.75 nmol of pNP.
DNA Quantification
Total DNA was quantified using a Quant-iT R© high sensitivity
dsDNA assay kit (Thermo Fisher Scientific, United Kingdom)
according to manufacturer instructions. Briefly, the Quanti-iT
reagent was diluted 1:200 with the provided buffer to create a
working solution. 90 µl of working solution was combined with
10 µL of lysate in triplicate in a black 96 well plate before shaking
for 15 s and leaving to conjugate for 10 min. Fluorescence was
then measured at λex: 485 nm, λem: 535 nm and converted to ng
of DNA per chip/culture well using a standard curve.
Cell Fixation
Prior to calcium and collagen staining and microscopy, samples
were fixed by removing the polyHIPE scaffold from the chip,
washing twice with PBS and submerging in 3.7% formaldehyde
for 30 min before rinsing a further two times in PBS. Samples
were stored at 4◦C in PBS until use.
Calcium Deposition
Matrix calcium deposition by the cells was measured using
Alizarin Red S (ARS) staining. Fixed samples were washed twice
with diH2O, then 2 mL of ARS working solution (1 w/v%
ARS dissolved in diH2O) was added to each scaffold and left
for 30 min. ARS solution was removed, and samples were
washed with diH2O with gentle orbital shaking until wash water
remained clear. 5% perchloric acid was used to destain the
samples for 15min with gentle orbital shaking before transferring
150 µL of destain solution in triplicate to a clear 96 well plate and
measuring absorbance at 405 nm. Absorbance was converted to
concentration of ARS (µg/mL) using a standard curve.
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Collagen Synthesis
Total collagen content was detected using Direct Red 80
(DR80) staining. Samples were washed three times with
water after performing the ARS assay and 2 mL of DR80
working solution (1 w/v% DR80 in saturated picric acid)
was added to each sample before leaving for 12 h with
orbital shaking at 100 rpm. After washing with diH2O,
0.2M sodium hydroxide:methanol (1:1) was added to destain
the samples and left for 20 min with orbital shaking at
100 rpm. 150 µL of destain solution was transferred in
triplicate to a clear 96 well plate and absorbance measured at
405 nm. The DR80 concentration was (µg/mL) calculated using
a standard curve.
Live Cell Tracking
For cell tracking experiments, hES-MPs were stained with
CellTrackerTM Red CMTPX (Thermo Fisher Scientific,
United Kingdom) prior to seeding according to manufacturer
instructions. Briefly, the dye was dissolved in DMSO and diluted
in α-MEM to a working concentration of 5 µM. After detaching
with trypsin, cells were centrifuged and suspended in the working
solution and incubated for 45 min. Cells were then recentrifuged
and seeded as normal. Cells were imaged using fluorescence
microscopy (Ti-E Nikon inverted microscope with a Nikon
Intensilight CHGFI fluorescence unit, Nikon).
Confocal Microscopy
A detailed protocol on the use of confocal microscopy for
these polyHIPEs has been reported previously (Owen et al.,
2016). Briefly, scaffolds with the highest resazurin reduction
fluorescence were stained with DAPI (40-, 6-diamidino-2-
phenylindole dihydrochloride) and Phalloidin-TRITC
(Phalloidin–Tetramethylrhodamine B iso-thiocyanate) in
order to view nuclei and f-actin, respectively. Confocal
images (512 × 512 pixels) were obtained using an upright
microscope (Axioskop 2 FS MOT Microscope, Carl Zeiss, Ltd.,
United Kingdom) with a 10 × objective (EC Plan-Neofluar
10 × /NA 0.30, Carl Zeiss, Ltd., United Kingdom) and a pixel
dwell time of 2.56 µs. DAPI was detected using a tuneable
Ti-Sapphire two-photon laser (λex: 800 nm, λem: 435–485 nm)
and Phalloidin-TRITC detected using a single photon laser (λex:
543 nm, λem: 565–615 nm).
Light Sheet Microscopy
On day 7 of culture samples were fixed and permeabilized
in 0.5% Triton-X 100 in PBS for 10 min. Blocking with 5%
goat serum was performed for 1 h at room temperature before
the primary antibody [anti-acetylated α-tubulin clone 6-11B-
1 produced in mouse (1 µg/ml)] was applied for 24 h at
5◦C. The secondary antibody [goat anti-mouse IgG H&L Alexa
Fluor R© 488 (2 µg/ml, Abcam, United Kingdom)] was then
applied for 1 h at room temperature followed by counterstaining
with DAPI. Three PBS washes were performed between each
of the previous steps. The samples were imaged using a Z.1
light sheet microscope (Zeiss). Samples were mounted in 0.8%
agarose (vol/vol in deionized water) within glass capillaries (size
4, Zeiss). Two 10 × NA 0.2 illumination optics (Zeiss) were
used to illuminate the samples in combination with a W plan-
apochromat 20 × /1.0 objective (Zeiss). Samples were excited
using a 405 nm (20 mW) and a 488 nm (50 mW) laser. Z-stacks
were taken and a maximum projection image created using the
accompanied ZEN software.
Histology
Fixed scaffolds were placed into cryosectioning molds and
covered with optimal cutting temperature (OCT) compound
(Leica). The molds were left under vacuum for 1 h to let the
OCT permeate into the pores of the polyHIPE. Samples were then
snap-frozen in a bath of liquid nitrogen before 8 µm sections
were cut using a cryostat (Leica CM1860UV) and collected on
slides. Slides were then stained with hematoxylin and eosin
solution (H&E), using standard protocol for frozen samples.
Slides were imaged using a light microscope (Motic).
Computational Fluid Dynamics
Simulations of culture medium (modeled as water) flowing along
the channels and through the porous polyHIPE were carried out
at various volumetric flow rates (Q: 0.8, 1.6, 2.4, and 3.2 mL/min)
which were assumed to be laminar with environmental pressure
at the outlet fixed at 101325 Pa. A constant temperature of
37◦C was assumed for all simulations using adiabatic walls
with surface roughness from 0.5 to 100 µm. The geometry
of all parts were generated in 3D including inlet and outlet
tubes of diameter 2 mm (area 3.142 mm2). A spreadsheet
table was generated to estimate values of velocity, Reynolds
number, shear stress, and pressure drop. This spreadsheet
used volumetric flow velocities on entrance and exit faces
and approximate values along narrow channels of around h:
0.3 mm x w: 0.38 mm (area reduced to A: 0.114 mm2)
with and estimated equivalent length from the 3D CAD L:
27 mm. Water was assumed to have a dynamic viscosity
µ: 7.75 × 10−4 kg/(m.s) and density ρ: 1000 kg/m3. Model
validation and simulation procedure is explained in detail at
the Supplementary Information.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism
(Version 7.00). To assess differences, either one-way or two-
way ANOVA (depending on whether a response was affected
by one or two factors) was used with Tukey’s or Sidak’s
multiple comparison test, respectively, to evaluate the statistical
significance. Differences were considered significant when
p < 0.05 and notable significant differences are indicated
on the figures or legends. All graphs are presented as
mean ± standard deviation with the number of replicates stated
in the figure legend.
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